
AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.
Avantor, Inc. provides products and services to clients in the biopharmaceutical, healthcare, education and government, advanced technologies and applied materials industries in America, Europe, Asia, the Middle East and Africa. The company is headquartered in Radnor, Pennsylvania.
| Revenue (TTM) | $6.55B |
| Gross Profit (TTM) | $2.11B |
| EBITDA | $948.10M |
| Operating Margin | 6.26% |
| Return on Equity | -9.44% |
| Return on Assets | 2.78% |
| Revenue/Share (TTM) | $9.65 |
| Book Value | $8.26 |
| Price-to-Book | 1.27 |
| Price-to-Sales (TTM) | 1.08 |
| EV/Revenue | 1.623 |
| EV/EBITDA | 92.85 |
| Quarterly Earnings Growth (YoY) | -33.30% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $682.75M |
| Float | $664.28M |
| % Insiders | 1.49% |
| % Institutions | 101.47% |
Volatility is currently expanding

AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.

RADNOR, Pa., July 1, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its second quarter 2026 financial results before the market opens on Wednesday, July 29, and will hold a conference call to discuss the results on the same day at 8:00 a.m.

Avantor (AVTR) reported earnings 30 days ago. What's next for the stock?

AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.

RADNOR, Pa., May 19, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Gerard (Jerry) Porreca has joined the company as Executive Vice President, Quality and Regulatory.

AVTR benefits from stable Q1 revenues and improving demand trends, though margin pressure and volume softness weigh on profitability.

Avantor, Inc. reported a slight beat on 1Q26 EPS and revenue, but underlying organic growth and margins remain under pressure. Negative organic growth, margin compression, and subdued cash flow signal only early stabilization, not a confirmed recovery, especially in the VWR segment. Management reaffirmed 2026 guidance and expects sequential improvement, but the recovery is execution-dependent and gradual, with margins likely to remain below historical peaks.

Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript

Avantor, Inc. (AVTR) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.23 per share a year ago.

Net sales of $1,581 million Net income of $43 million; Adjusted EBITDA of $219 million Diluted GAAP EPS of $0.06; adjusted EPS of $0.17 Operating cash flow of $59 million; free cash flow of $25 million Reaffirms FY 2026 guidance RADNOR, Pa., April 29, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first fiscal quarter ended March 31, 2026.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AVTR and any ticker you trade — then tracks every position and per-strategy win rate.